Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology (PR)

16 Responses Abattis News | Health Canada | Northern Vine | Raybot

VANCOUVER, BC / ACCESSWIRE / April 26, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis“) is pleased to announce that it has signed an exclusive distribution agreement, effective April 20, 2017 (the “Agreement“), with Suzhou Raybot Material Tech Corp. (“Raybot“). The Agreement allows Abattis to use Raybot’s proprietary extraction technology and to exclusively […]

Abattis Announces the Appointment of Dr. Shuang Xie as a Director and Provides Progress Report on Initiatives in China (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / November 14, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce the appointment of Dr. Shuang Xie to the Board of Directors. Dr. Xie recently joined Abattis as the Chief Technology Advisor and continues in that capacity. Abattis is also pleased provide an update on […]

Update: New Science Advisor and Comptroller Appointment to Abattis (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / September 27, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce the appointment of Dr. Shuang Xie as its newest Science and Technology Advisor. Dr. Xie graduated from Zhejiang University in 1987 and Queen’s University in 1993. Dr. Xie has been widely published and holds […]